GINKGO BIOWORKS HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$7.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $3.94M.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$11.60M, a 230.80% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$6.62M.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $20.33M.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $10.38M.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$40.44M, a 339.29% decline from fiscal 2023.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $16.90M.
- GINKGO BIOWORKS HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was -$39.64M, a 188.49% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$7.66M 10-Q · filed 2026-08-06 | -$14.27M derived: sum of 3 quarters · filed 2026-08-06 | $6.06M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$11.60M 10-Q · filed 2026-05-07 | -$18.22M derived: sum of 2 quarters · filed 2026-05-07 | $2.12M derived: sum of 3 quarters · filed 2026-05-07 | -$10.09M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$6.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $13.72M derived: sum of 2 quarters · filed 2026-02-26 | $1.51M derived: sum of 3 quarters · filed 2026-08-06 | $10.38M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $20.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.12M derived: sum of 2 quarters · filed 2026-08-06 | $16.99M 10-Q · filed 2025-11-06 | $7.65M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$12.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.34M 10-Q · filed 2026-08-06 | -$5.13M 10-Q · filed 2025-08-07 | -$12.68M derived: sum of 3 quarters · filed 2026-08-06 | -$54.64M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $8.87M 10-Q · filed 2026-05-07 | $6.42M 10-Q · filed 2025-05-06 | -$470.00K derived: sum of 2 quarters · filed 2026-05-07 | -$42.43M derived: sum of 3 quarters · filed 2026-05-07 | -$42.44M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$9.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$51.30M derived: sum of 2 quarters · filed 2026-02-26 | -$51.31M derived: sum of 3 quarters · filed 2026-02-26 | -$40.44M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$41.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$41.97M derived: sum of 2 quarters · filed 2025-11-06 | -$31.10M 10-Q · filed 2025-11-06 | -$9.38M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $10.86M 10-Q · filed 2025-08-07 | $32.59M derived: sum of 3 quarters · filed 2026-02-26 | $31.77M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $10.87M 10-Q · filed 2025-05-06 | $32.59M derived: sum of 2 quarters · filed 2026-02-26 | $31.77M derived: sum of 3 quarters · filed 2026-02-26 | $8.69M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $21.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $20.90M derived: sum of 2 quarters · filed 2026-02-26 | -$2.18M derived: sum of 3 quarters · filed 2026-02-26 | $16.90M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$818.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$23.90M derived: sum of 2 quarters · filed 2024-11-12 | -$4.82M 10-Q · filed 2024-11-12 | -$32.61M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | -$23.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.00M 10-Q · filed 2024-08-08 | -$7.00M 10-Q · filed 2023-08-09 | -$31.79M derived: sum of 3 quarters · filed 2025-02-25 | -$30.76M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $19.08M 10-Q · filed 2024-05-09 | $9.40M 10-Q · filed 2023-05-10 | -$8.71M derived: sum of 2 quarters · filed 2025-02-25 | -$7.68M derived: sum of 3 quarters · filed 2025-02-25 | -$30.53M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | -$27.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$26.76M derived: sum of 2 quarters · filed 2025-02-25 | -$49.61M derived: sum of 3 quarters · filed 2025-02-25 | -$39.64M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$21.82M derived: sum of 2 quarters · filed 2023-11-08 | -$11.85M 10-Q · filed 2023-11-08 | -$15.64M 10-Q · filed 2022-11-14 | $3.35M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$22.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$12.88M 10-Q · filed 2023-08-09 | -$12.76M 10-Q · filed 2022-08-15 | $2.32M derived: sum of 3 quarters · filed 2024-02-29 | $12.78M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $9.97M 10-Q · filed 2023-05-10 | $25.17M derived: sum of 2 quarters · filed 2024-02-29 | $35.63M derived: sum of 3 quarters · filed 2024-02-29 | $37.96M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $25.66M derived: sum of 2 quarters · filed 2024-02-29 | $27.99M derived: sum of 3 quarters · filed 2024-02-29 | $44.80M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $10.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $12.79M derived: sum of 2 quarters · filed 2022-11-14 | $29.60M 10-Q · filed 2022-11-14 | $36.57M derived: sum of 4 quarters · filed 2023-03-13 | |||
| 2021-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $19.14M 10-Q · filed 2022-08-15 | $26.11M derived: sum of 3 quarters · filed 2023-03-13 | ||||
| 2021-03-31 | $16.81M 10-Q · filed 2022-05-16 | $23.78M derived: sum of 2 quarters · filed 2023-03-13 | |||||
| 2020-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $8.66M 10-K · filed 2023-03-13 | |||||
| 2020-09-30 | $1.69M 10-Q · filed 2021-11-15 | ||||||
| 2019-12-31 | $4.17M 10-K · filed 2022-03-29 |